FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

143571000237105: Plasma clinical chemistry (observable entity)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 12-Apr 2023. Module: SNOMED CT United Kingdom pathology and laboratory medicine production content extension module

Descriptions:

Id Description Lang Type Status Case? Module
215451000237114 Plasma clinical chemistry (observable entity) en Fully specified name Active Entire term case insensitive SNOMED CT United Kingdom pathology and laboratory medicine production content extension module
215461000237112 Plasma clinical chemistry en Synonym Active Entire term case insensitive SNOMED CT United Kingdom pathology and laboratory medicine production content extension module

405 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Plasma clinical chemistry Component Chemical true Inferred relationship Existential restriction modifier 1
Plasma clinical chemistry Inheres in Plasma true Inferred relationship Existential restriction modifier 1
Plasma clinical chemistry Is a Blood clinical chemistry observable true Inferred relationship Existential restriction modifier
Plasma clinical chemistry Direct site Plasma specimen true Inferred relationship Existential restriction modifier 1
Plasma clinical chemistry Property Quantity concentration true Inferred relationship Existential restriction modifier 1
Inbound Relationships Type Active Source Characteristic Refinability Group
Arbitrary concentration of antibody to myelin associated glycoprotein in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of bile acids, total in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Arbitrary concentration of carbohydrate deficient transferrin in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Arbitrary concentration of voltage-gated calcium-channel antibody in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of plasma anion gap (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Arbitrary concentration of protein S in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of thymine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of vitamin E in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of vitamin K1 epoxide in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of threonine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of strontium in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of beta carotene in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of chromogranin B in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of pancreastatin in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of antidiuretic hormone (vasopressin) in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of argatroban in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of acetoacetate in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of desmethylclozapine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of lysine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of vitamin B1 in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of theophylline in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of androstenedione in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Arbitrary concentration of coagulation factor IX in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Recumbent arbitrary concentration of renin in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of insulin in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of 3-hydroxyoleylcarnitine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of 3-hydroxymyristoylcarnitine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of methadone in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of beta-glucosidase in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Arbitrary concentration of alpha-3 ganglionic acetylcholine receptor antibody in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of ammonia in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of sulphonylurea in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of acylcarnitine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of inhibin B in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of amphetamine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of teicoplanin in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of beta 2 microglobulin in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of aspartic acid in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of beta-hydroxybutyrate in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Arbitrary concentration of coagulation factor X in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of codeine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of glutamate in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of lorazepam in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of beta-human chorionic gonadotropin, free in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of cyclosporin in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of streptomycin in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of linoleylcarnitine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of tiglylcarnitine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of haptoglobin in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of ghrelin in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of sucrose in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of globulin in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of folate in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of 17-oxosteroid in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of cystathionine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of 3-methylcrotonylcarnitine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of methylenedioxymethamphetamine (ecstasy) in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of calcitonin in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of insulin-like growth factor binding protein 3 in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Arbitrary concentration of gamma-glutamyltransferase in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of methemalbumin in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Arbitrary concentration of amylase in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of prostate specific antigen, free in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of gastrin in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Arbitrary concentration of glycine receptor antibody in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of methylphenidate in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of ethanolamine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of inhibin A in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of total carbamazepine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of vancomycin in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of beta-alanine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of 2,8-dihydroxyadenine in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Mass concentration of fentanyl in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of total iron binding capacity in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of 11-deoxycortisol in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier
Substance concentration of glucagon in plasma (observable entity) Is a True Plasma clinical chemistry Inferred relationship Existential restriction modifier

Start Previous Page 4 of 4

This concept is not in any reference sets

Back to Start